Uncommon leg ulcers in the lower extremity  by Labropoulos, Nicos et al.
Uncommon leg ulcers in the lower extremity
Nicos Labropoulos, PhD, DIC, RVT,a,b Danielle Manalo, MD,a Nima P. Patel, MD,b
Jay Tiongson, MD,a Landon Pryor, MD,a and Athanasios D. Giannoukas, MD,c Maywood, Ill; Newark, NJ;
and Larissa, Greece
Objective: To determine the prevalence of uncommon ulcers, unrelated to venous or arterial etiology, in patients
presenting to vascular clinics.
Methods: This was a multicenter prospective study of consecutive patients presenting with lower extremity ulceration. The
settings were university hospital outpatient centers and venous clinics. A total of 799 limbs in 710 patients with leg ulcers
were evaluated. Patients with venous ulcer disease and with evidence of arterial disease with an ankle-brachial index less
than 0.7 were excluded from the study. Out of 710 patients, 17 patients with a total of 21 limbs fit the criteria for
inclusion. All limbs included in this study underwent physical examination, ankle-brachial index measurements, duplex
ultrasonography, and skin biopsies.
Results: The mean age of patients with uncommon ulcers was 65.6 years, and the mean duration was 5.5 years. A total of
2.1% of all leg ulcers seen were due to uncommon etiology unrelated to venous or arterial pathology. Most of these ulcers
were located in the medial lower calf (n  19). In six patients with ulcers, the histology did not reveal any specific cause;
five had a neoplasia, three had chronic inflammation, two had sickle cell disease, two had vasculitis, one had rheumatoid
arthritis, one had pyoderma gangrenosum, and one had ulcer due to hydroxyurea.
Conclusions: The prevalence of leg ulcers unrelated to arterial and venous disease that presented with signs and symptoms
of chronic venous disease was 2.1%. Their etiology is variable, most often including vasculitis, neoplasia, metabolic
disorders, infection, and other rare causes. Early identification of uncommon ulcers may facilitate timely and appropriate
management. (J Vasc Surg 2007;45:568-73.)Chronic leg ulceration is a common condition with
limited epidemiologic data. Some studies report prevalence
rates between 0.18% and 2% of the European population1,2
and up to 5% of the population over 65 years of age.1 The
overwhelming majority of leg ulcers are of venous origin,
cited in the literature from anywhere between 45% and 90%
of all leg ulcers.1,2 The second most common cause of leg
ulcers is arterial occlusive disease, followed by neuropathic
ulcers. Interpretation of these data has been complicated by
the recent shift toward arterial and mixed ulcers, likely
because of the aging population and improved detection of
arterial disease.1 The high prevalence of risk factors for
atherosclerotic occlusion, especially in Western popula-
tions, also contributes to the increasing incidence of ulcer-
ation.2 Proper identification of the etiology of leg ulcers is
imperative for appropriate management, because incorrect
treatment may cause significant harm.2
Venous ulcers are classically located in the gaiter area
with the appearance of an irregular border, fibrinous debris,
extensive granulations, and weeping; the surrounding skin
may demonstrate edema, hemosiderin pigmentation, hy-
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568perkeratosis, atrophie blanche, or cellulitis.1,2 Some ulcers
that appear to be venous are of other etiologies. Carcino-
matous growth can be masked as a deteriorating leg ulcer.3
Case reports have described livedoid vasculitis or calciphy-
laxis in patients who were otherwise expected to have
venous ulcers.4,5 However, information on ulcers with
uncommon etiologies is lacking. Therefore, this study was
performed to determine the prevalence of these ulcers in
patients presenting to a vascular clinic.
METHODS
A total of 710 patients and 799 limbs with leg ulcers
from various centers were evaluated. Patients with leg
ulcers of nonvenous etiology and nonarterial ischemic dis-
ease were included in the study. They were selected from
consecutive patients with leg ulcers (class 6 according to the
CEAP classification6) attending a venous clinic. The ulcers
were associated with signs and symptoms of chronic venous
disease. These included pain, swelling, burning sensation,
itching, heaviness, restless limb, skin discoloration, and
lipodermatosclerosis. They were located on the medial
malleolus, lateral malleolus, or calf. Patients with foot ul-
cers were not included in the study. Appreciable arterial
disease that may have contributed to the ulcer formation
was eliminated by including only those patients with an
ankle-brachial index of greater than 0.7. These patients
were also excluded from the multicenter study and there-
fore were not available for this study. Patients with foot
ulcers were unlikely to have venous disease and were ex-
cluded as well.
Duplex ultrasonography was used to investigate the veins
in the lower extremity from groin to ankle. The femoropop-
liteal veins; deep calf veins; great saphenous veins, small saphe-
dial; n
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perforating veins were evaluated in all limbs. Reflux was con-
sidered to be present when the retrograde flow lasted longer
than 1 second in the femoropopliteal veins and more than
0.5 seconds in the superficial and deep calf veins. Evidence
of thrombosis was documented by the noncompressibility
of the vein, visualization of the thrombus, filling defects on
color mode, intraluminal webs, recanalized intraluminal
channels, and wall thickening. Limbs with reflux or ob-
struction were excluded.
The physical examination, the ankle-brachial index,
and the ultrasound investigation were performed by spe-
cialists in vascular medicine or vascular surgery. The partic-
ipating centers had at least 3 years of experience in exam-
ining patients with chronic venous disease. All limbs that
were included in this study underwent skin biopsies. A
3-mm punch biopsy or incisional biopsy provides a full-
thickness tissue sample with minimal scarring.7 The data
were inserted in a customized Microsoft Access database
(Microsoft Corp, Redmond, Wash).
RESULTS
Out of 799 patients with leg ulcers, 17 patients with 21
ulcerated limbs were included in the study (Table I). Four
patients had bilateral ulcers. The mean age was 65.6 years
(SD, 15.2 years), and the mean duration of the ulcers was
5.5 years. The location of the ulcers was predominately on
the medial aspect of the lower calf (n  19): one was
located in the anterolateral and one in the posterior aspect
of the calf. Three patients demonstrated venous reflux by
duplex ultrasonography. Two of them underwent stripping
of the great saphenous vein and stab avulsions of the
varicosities. The third patient had injection sclerotherapy of
Table I. Characteristics of the ulcers found on 21 patients
Sex Age (y) Limb Location on calf Duration (y)
M 63 L u-l/med 3
R u-l/med 3
F 72 L l/med 5
R l/med 5
F 52 L m-l/med 4
M 73 R l/med 8
M 54 R l/ant-lt 2
M 68 L m/post 1
M 79 L l/med 16
F 76 R l/med 18
F 73 R l/med 15
F 64 L m-l/med 3
R m-l/med 3
M 71 L l/med 4
F 82 R m-l/med 7
F 73 R l/med 14
M 78 L m/med 2
59 L l/med 0.17
M 17 R l/med 0.33
M L l/med 0.25
F 62 R l/med 0.75
ABI, Ankle-brachial index; u, upper calf; m, mid calf; l, lower calf; med, mea calf tributary. The deep veins were normal in all threepatients, and no other venous abnormality was found.
Despite of the successful treatment for the reflux, the ulcers
still persisted. The third patient had also an ankle-brachial
index of 0.7, which decreased to 0.58 after exercise. He had
a significant stenosis in the superficial femoral and popliteal
arteries. Both lesions were successfully treated with percu-
taneous transluminal angioplasty, and the ankle-brachial
index increased to 0.92. The ulcer was reduced in size after
the arterial and venous treatment but never healed. None of
the patients had trauma, deep venous thrombosis, superfi-
cial venous thrombosis, congestive heart failure, chronic
renal failure, hepatic failure, diabetes mellitus, or depen-
dency.
The size of the ulcer varied. The largest diameter
ranged from 2 to 14 cm. The ulcers had characteristics of a
chronic wound. Most of them were highly inflamed and
had necrotic tissue and hyperproliferation in the sur-
rounding skin. On closer inspection, there were different
characteristics in many ulcers, but this information was
not systemically collected. When the patients were found
not to have arterial or venous disease, they were sent to a
dermatologist and had a skin biopsy.
Three patients were being treated with antibiotics for
cellulitis with concurrent lymphedema. Two other pa-
tients were also being treated with antibiotics. These two
patients were given antibiotics by their referring physi-
cians but were not shown to have an infection. Obesity
was not an exclusion factor, and two of our patients with
undetermined pathology were obese, with a body mass
index of 34 and 39 kg/m2.
Pathology was identified in 15 limbs of 13 patients
(Table II). Two patients had no histologic analysis because
the biopsy specimens were lost in the pathology depart-
Duplex ABI Medication Pathology
nl abx Undetermined
nl abx Undetermined
nl Vasculitis
nl Vasculitis
nl abx Chronic inflammation
nl abx Chronic inflammation
nl abx Chronic inflammation
nl Kaposi sarcoma
nl Carcinoma
ous reflux nl Squamous cell carcinoma
ous reflux nl Squamous cell carcinoma
nl Undetermined
nl Undetermined
nl No histology
nl abx No histology
nl Basal cell carcinoma
nl Pyoderma gangrenosum
nl Hydroxyurea
nl Sickle cell
nl Sickle cell
d reflux 0.7 Rheumatoid arthritis
l, normal; abx, antibiotics; post, posterior; ant-lt, anterior lateral.nl
nl
nl
nl
nl
nl
nl
nl
Ven
Ven
nl
nl
nl
nl
nl
nl
nl
nl
nl
Milment and the patients refused to have another biopsy
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had undetermined pathology despite histologic study. Two
patients with venous reflux had a histologic diagnosis of
squamous cell carcinoma (SCC). One patient each had
ulcer pathology that revealed Kaposi sarcoma, carcinoma,
basal cell carcinoma (BCC), pyoderma gangrenosum, and
hydroxyurea. The patient with the Kaposi sarcoma was
immunosuppressed. Histologic diagnoses were obtained in
two patients with bilateral ulcers. One patient had nonspe-
cific vasculitis; the other had pathology that confirmed
sickle cell anemia.
One patient with a combination of mild reflux and an
ankle brachial index of 0.7 had an ulcer etiology of rheu-
matoid arthritis. Three patients with cellulitis receiving
antibiotic therapy had pathology consistent with chronic
inflammation.
DISCUSSION
The differential diagnosis for leg ulcers is extensive.
Fortunately, most of the conditions are rare and exist in
the literature as small case series or case reports. The
most common etiologies of leg ulcers can be grouped
into venous, arterial, or neuropathic ulcers. In our study,
uncommon leg ulcers accounted for 2.1% of all leg
ulcers. Appendix II (online only) includes the results from
a literature search for case reports of uncommon leg ulcers
in adults. Clearly, our study has underestimated the preva-
lence of uncommon leg ulcers because many of those
patients do not go to vascular clinics. This was also because
in this study, only ulcers that had a venous appearance and
location were included. Furthermore, the rest of the pa-
tients who had venous etiology and arterial disease did not
have a biopsy performed. Therefore, other patients from
the same pool were missed.
One patient in our study had pyoderma gangrenosum
located on the medial aspect of the mid calf. It is an
uncommon but impressive ulcer of unknown etiology. Fifty
Table II. Pathology results
Pathology Limbs No. Patients
Undetermined 5 3
No histology available* 1 1
Chronic inflammation 3 3
SCC 2 2
Kaposi sarcoma 1 1
Carcinoma 1 1
BCC 1 1
Sickle cell anemia 2 1
Vasculitis 2 1
Pyoderma gangrenosum 1 1
Hydroxyurea 1 1
RA 1 1
Total 21 16
% of uncommon ulcers out of
total leg ulcers 1.3% 2.1%
SCC, Squamous cell carcinoma; BCC, basal cell carcinoma.
*The histology specimen was lost, and the biopsy was not repeated.percent of cases are associated with chronic disease, and theother 50% are considered idiopathic.8 Lesions are most
commonly found on the lower legs, but they may occur
anywhere on the skin.9 Usually they begin as painful pus-
tules, with rapid development of necrosis and ulceration.
Fully established lesions show single or multiple ulcers with
well-defined, raised, purple, serpiginous, and undermined
borders.7 There are also several variants, and this can make
the diagnosis difficult. Investigations including skin biopsy
should be undertaken to rule out other etiologies.7 The
initial goals of treatment are to address any underlying
disorders and provide adequate wound care. Systemic treat-
ment with corticosteroids followed by cyclosporine or
other immunomodulatory agents has been successful in
treating pyoderma gangrenosum.2
Leg ulcers are a common complication in patients with
homozygous sickle cell disease and those with associated
-thalassemia, with prevalence rates from 8% to 10% of
patients aged 10 to 50 years.10 Contributing factors to
ulcer formation include vessel obstruction by sickled cells,
increased venous and capillary pressure, secondary bacterial
infection, and decreased oxygen-carrying capacity of the
blood.9 The medial malleoli are the most common site of
leg ulceration in sickle cell disease and in other chronic
hemolytic anemias, suggesting perhaps that stasis may play
a role in leg ulceration associated with chronic hemolytic
anemia. These ulcers are often bilateral, persistent, and
recurrent. This was illustrated in the patient in our study
with bilateral ulcers on the medial aspect of the lower
calves. Depending on the extent of the lesions, treatment
modalities may include bed rest, debridement, wet-to-dry
saline dressings, blood transfusions, and topical antibiot-
ics.11 Skin grafts and myocutaneous flaps may be required
for extensive ulcers.
Rheumatoid arthritis and Felty syndrome are com-
monly associated with leg ulcers. Studies report that 9% to
10% of patients with rheumatoid arthritis12,13 and approx-
imately 25% of patients with Felty syndrome have leg
ulcers. The etiologies of these ulcers are frequently multi-
factorial. Concurrent venous or arterial disease is often
contributory, as seen in our study with one patient who had
rheumatoid arthritis with concurrent mild venous reflux
and an ankle-brachial index of 0.7. Other causes include
vasculitis, diabetes, deformities, trauma, or pressure from
ill-fitting shoes.2 Occasionally the cause is uncertain. Oien
et al12 reviewed 20 cases of leg ulcers in patients with
rheumatoid arthritis and reported 1 patient with a leg ulcer
of undetermined etiology. No further discussion was made
regarding this finding. This nonvenous, nonarterial ulcer
likely represents a less common ulcer similar to those seen
in our study. Two patients had undetermined pathology
despite histologic study.
Leg ulcers have been documented as a rare complica-
tion of long-term hydroxyurea treatment in patients under-
going therapy for myeloproliferative disorders.14 These
painful, persistent ulcers may not manifest until after a
duration of 2 to 15 years of treatment.2 Usually located on
the malleoli, the ulcer appears fibrous, with atrophic peri-
ulcerous skin. Twenty-four case reports were found in the
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retrospective study of 41 cases of leg ulceration during
hydroxyurea therapy noted that 80% of the ulcers com-
pletely recovered after discontinuation of the drug; the rest
had improvement and reduction in ulcer size.15 One pa-
tient in our study had a hydroxyurea ulcer on the medial
aspect of the lower calf for 2 months. The duration of
hydroxyurea therapy was 3 years. After the discontinuation
of the drug, the ulcer was healed.
Calciphylaxis is a rare condition that can develop as a
complication of secondary hyperparathyroidism, which
most commonly occurs in patients with end-stage renal
disease. Up to 4% of patients receiving renal dialysis may
show signs of calciphylaxis.16 It is characterized by exces-
sive calcium deposition in the skin, soft tissues, and arteries.
Patients may present with a range of skin manifestations,
from painful subcutaneous nodules to nonhealing extrem-
ity ulcers and gangrene.17 The exact pathogenesis remains
uncertain. Ischemic necrosis preferentially affects cutane-
ous vessels of the trunk and limb girdle. There is often rapid
onset, with large, painful plaques that evolve into full-
thickness necrosis and gangrene, similar to that seen with
warfarin-associated necrosis.7 Treatment includes local
wound care, correction of the calcium/phosphorus ratio,
and surgical evaluation for possible arterial revasculariza-
tion and parathyroidectomy.16
Five patients had ulcers of neoplastic origin. Two pa-
tients with venous reflux presented with ulcer etiologies of
SCC. As mentioned previously, stasis ulcers are likely to
degenerate into malignancy.3 The ulcers may often be
painless, appear hypertrophic or hemorrhagic with irregular
borders, and exhibit a slow progressive growth. The dura-
tion of each ulcer with SCC in our study was 18 and 15
years. One epidemiologic study noted an increase in the
incidence of SCC in venous ulcers.18 It is the second most
common form of skin cancer and often arises on sun-
exposed areas of middle-aged and elderly individuals of fair
complexion. It can also occur on non–sun-exposed areas
such as the genitals and mucous membranes. It is interest-
ing to note that SCC is the most common type of skin
cancer in African Americans, often involving skin that is not
chronically sun-exposed.17 The ulcers with SCC in our
study were in the gaiter area, a location consistent with
venous ulcers.
BCC is the most common type of skin cancer, typically
arising on areas of chronic sun exposure, especially the head
and neck. However, 8% of BCC arises on the lower extrem-
ity.19 It may appear as a chronic ulcer refractory to treat-
ment or may even appear as a benign ulcer with adequate
granulation tissue, without the classic rolled pearly border
or surface telangiectasia. One patient in our study had a
histologic diagnosis of BCC. He had an ulcer that was
located in the lower calf/malleolus. Most lesions of both
SCC and BCC can be treated with various surgical modal-
ities, including cryosurgery, electrodesiccation and curet-
tage, excision, and Mohs surgery.20
A variety of other atypical causes, as well as idiopathic or
unknown causes of leg ulcerations, have been reported.21For instance, vasculitis is a known condition that causes
ulcerations.22 Scott et al23 diagnosed leg ulcers in 38% of
patients with systemic rheumatoid vasculitis. Both limbs in
one patient in our series were diagnosed with vasculitis
by ulcer biopsy, and this was the likely cause for persis-
tence. The diagnosis of vasculitis as the causative agent
for an ulcer is difficult, given the low yield associated
with ulcer edge biopsies.24 Furthermore, microbial col-
onization of the ulcer per se can cause a histologic
picture of bacterial necrotizing vasculitis. Ulcers in four
limbs in our patient population were not attributable to
any of the known causes. The patients had a normal
duplex scan and biopsy of the ulcer.
Three patients with cellulitis and lymphedema had
chronic inflammation on the biopsy sample. Probably these
patients do not need to have a biopsy, but it is difficult to
make such a recommendation because the sample is so
small. These patients had no other vascular disease.
Usually patients with lymphedema and ulceration have
arterial or venous disease or cancer.25,26 The prevalence
of lymphedema alone in a large prospective study was
2.5% (17/689).27
An ulcer that fails to heal after 3 to 4 months of wound
care should be biopsied. The biopsy should be performed
of the ulcer edge for a diagnosis and to rule out malignancy.
If a biopsy is intended to determine an uncommon cause of
ulceration, including vasculitis, both the edge of the ulcer
and the ulcer bed should be sampled.28 Punch biopsies
(3-4 mm) or a wedge or a rectangular biopsy using a scalpel
will harvest sufficient tissue for histologic analysis. If malig-
nancy is suspected, several biopsies should be obtained
from the wound bed by using either a shave or punch
method. If an atypical wound infection is considered, a
biopsy for tissue culture should be performed.29 A total of
two patients with four limbs in our study had pathology
reports showing undetermined pathology. If an unusual leg
ulcer is present and the biopsy is not helpful, more specific
tests should be part of the workup. For example, cryo-
globulins may be associated with hepatitis C and leg ulcer-
ation. Therefore, hepatitis C serologies and serum levels
of cryoglobulins may be helpful in making the diagno-
sis.30 It is important to keep in mind that there are
numerous staining techniques available to detect vascu-
lar pathology, micro-organisms, malignancies, dermato-
logic disorders, or storage diseases. The pathologist
should receive detailed information about the clinical
problem and the potential differential diagnoses.2 In our
case, an extensive battery of tests was performed, but all
results were nondiagnostic.
In general, though, we recommend arterial and venous
testing before any other test because the prevalence of
vascular disease has been shown to be very high in many
clinical and epidemiologic studies. Also, many ulcers have
mixed etiology, and arterial and venous testing can demon-
strate the vascular pathology that may contribute to the
ulcer formation.
JOURNAL OF VASCULAR SURGERY
March 2007572 Labropoulos et alCONCLUSION
Extremely rare ulcers of numerous etiologies exist only
as case reports scattered throughout the literature. We
found uncommon leg ulcers in 17 patients out of 710
patients evaluated for leg ulcers. Vasculitic, bacterial, viral,
metabolic, and neoplastic ulcers have been described in
single case reports or small case series. Such ulcers and those
refractory to initial treatment necessitate referral for further
evaluation. As mentioned previously, biopsies are not al-
ways confirmatory. However, identification of these pa-
tients in the setting of a vascular clinic may provide more
accurate data on the prevalence and etiology of uncommon
leg ulcers. More importantly, it may facilitate the earlier
identification neoplastic ulcers.31-88
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Case reports of nonvenous, nonarterial ulcers in adults, 1966 to July 2006
References Condition Most common location Morphology Comments
31-33 Pyoderma gangrenosum Lower legs but can
appear anywhere on
skin
Well-defined, raised, purple, serpiginous,
undermined border; rapid
development of necrosis and ulceration
9, 34, 35 Sickle cell anemia Medial malleoli; often
bilateral
New ulcers are painful, inflammation may
arise on old scar; may be purulent,
have poor granulation tissue, and be
nonhealing if 10 cm
Can occur spontaneously
or as a result of local
trauma
36-38 Rheumatoid arthritis, Felty
syndrome
May occur in unusual
locations
Smooth, undulating, irregular
“geographic” shape; can be associated
with livedo reticularis and palpable
purpura
Often multifactorial,
including concurrent
venous or arterial
disease, vasculitis,
diabetes, deformities,
trauma, or pressure
13, 39-44 Hydroxyurea Malleoli Painful, persistent; fibrous-appearing with
atrophic periulcerous skin
1, 45-48 Calciphylaxis Trunk and limb girdle Painful subcutaneous nodules to
nonhealing extremity ulcers and
gangrene.
Associated with chronic
renal failure
49, 50 Osteomyelitis Foot Several types: nonhealing superficial ulcer
with thickened, sclerosed bone covered
partly by a thin layer of epithelium;
deep ulcer, where base consists of
excavated bone; or multiple sinuses;
sclerotic bone changes and periosteal
thickening seen by radiography
17, 51-54 Squamous cell carcinoma When mucosal surfaces
are excluded, the
most common
location is the lower
extremity
May be hypertrophic or hemorrhagic;
irregular borders; lymphadenopathy;
often painless; slow progressive growth
The most common type
of skin cancer in
blacks; predisposing
factors are burn scars
and chronic infection
18, 55-57 Basal cell carcinoma 8% of basal cell
carcinomas arise on
the lower extremity
Chronic ulcer refractory to treatment;
may appear benign (ie, healthy
granulation tissue, no rolled pearly
border or surface telangiectasia)
1, 58, 59 Necrobiosis lipoidica
(diabeticorum)
Anterior lower limb Oval or irregular reddish brown plaque
with central atrophy and translucent
telangiectasias
60, 61 Thalassemia Medial malleoli Chronic, nonpainful; shallow with
irregular shape; surrounding skin may
have no erythema or
hyperpigmentation
Higher prevalence of leg
ulcers in sickle cell
anemia and that
associated with alpha
thalassemia
62, 63 Scleroderma Lower limb Ischemic skin lesions varying form digital
pitting scars to wide ulcers
Concurrent arterial or
venous disease is
common—a common
complication of
squamous cell
carcinoma and poorly
responsive to common
pharmacologic
treatments
64-66 Prolidase deficiency Thigh and lower leg Skin fragility with leg ulceration and
characteristic pitting and scarring;
telangiectasias, purpura, lymphedema
can also be present; histology is
nonspecific
Hereditary condition
diagnosed in
childhood
7, 67, 68 Livedo reticularis Lower legs, feet, ankles Fishnet-like skin mottling; color changes
from reddish blue to deep blue
mottling upon cold exposure; can
progress to hemorrhagic blisters and
punched-out ulcers; can heal with
atrophie blanche
Nonspecific clinical
reaction associated
with a variety of
conditions
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References Condition Most common location Morphology Comments
69 Purpura Lower legs and feet Purpura often preceded by a burning
sensation or pain localized to the
affected skin areas associated with
edema; often followed by ulcerations
after exposure to severe cold leading to
scar formation and brownish
pigmentation
Associated with essential
cryoglobulinemia or
essential
cryofibrinogenemia
70, 71 Polyarteritis nodosa Ankle, lower leg May present with atrophie blanche
72, 73 Leprosy Legs and arms Posttraumatic with secondary infection or
erythema necroticans: angular inflamed
lesions that slough to leave deep ulcers
74, 75 Sarcoidosis Cutaneous involvement
in approximately 25%
of cases; ulcerative
lesions are rare but
usually occur on the
legs
Small, usually 1-2 cm, frequently resolve
with systemic corticosteroid therapy
76 Livedo vasculitis Lower extremities Focal purpura proceeding to configurate,
stellate, infarctive ulcers covered with
dark adherent eschar surrounded by a
border of inflammation; can heal with
atrophie blanche
77-80 Other anemias Variable
81 Erythema induratum of
Bazin
Posterior aspect of
lower third of calves
Persistent and recurrent nodules that
often ulcerate in cold weather; lower
calves may plump with erythrocyanotic
circulation and follicular
hyperkeratosis; ulcers are irregular and
shallow with bluish tense borders;
usually heal spontaneously within
several months, leaving atrophic
hyperpigmented areas; histologically
appears as a tuberculoid granuloma
with or without caseation and may
involve subcutaneous vessels or fat
Significant number of
patients may have a
past or present history
of tuberculosis
82, 83 Behçet disease Oral and genital; rarely
on the legs
May have features of thrombosis and/or
vasculitis
84, 85 Panniculitis Variable Variable Case reports revealed
that panniculitis was a
manifestation of
subcutaneous tophus,
B-cell lymphoma,
calciphylaxis, and
Candida albicans
86, 87 Erythema elevatum diutinum
(necrotizing vasculitis)
Legs Large erythematous ulcerated nodules;
purpuric eruptions surrounded by
warm erythematous skin;
depigmentation at site of old healed
ulcer; histologically a form of
leukocytoclastic vasculitis characterized
by an abundant infiltrate of neutrophils
84, 88 Diphtheria Legs Chronic, nonhealing, slow growing;
covered with purulent membrane
surrounded by necrotic zone
